CRISPR

CRISPR1-gper1

ID
ZDB-CRISPR-180420-1
Name
CRISPR1-gper1
Previous Names
None
Target
Sequence
5' - GGCTGTGGCAGATCTTATTC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
uab102 gper1
Expression
Gene expression in Wild Types + CRISPR1-gper1
No data available
Phenotype
Phenotype resulting from CRISPR1-gper1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-gper1
Phenotype Fish Conditions Figures
heart contraction decreased rate, abnormal gper1uab102/uab102 chemical treatment by environment: fulvestrant Fig. 2 with image from Romano et al., 2017
female organism estrogen decreased amount, abnormal gper1uab102/uab102 standard conditions Table 1 from Romano et al., 2017
heart contraction increased rate, abnormal gper1uab102/uab102 chemical treatment by environment: 17beta-estradiol Fig. S1 from Romano et al., 2017
whole organism 3,3',5-triiodo-L-thyronine decreased amount, abnormal gper1uab102/uab102 standard conditions Fig. 5 from Romano et al., 2017
heart contraction rate, ameliorated gper1uab102/uab102 chemical treatment by environment: 3,3',5-triiodo-L-thyronine Fig. 5 from Romano et al., 2017
heart contraction decreased rate, abnormal gper1uab102/uab102 chemical treatment by environment: 17beta-estradiol Fig. 2 with imageFig. 5 from Romano et al., 2017
heart contraction decreased rate, abnormal gper1uab102/uab102 standard conditions Fig. 2 with imageFig. S7 from Romano et al., 2017
heart looping process quality, abnormal gper1uab102/uab102 (AB) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 7 from Souder et al., 2019
pericardium edematous, abnormal gper1uab102/uab102 (AB) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 7 from Souder et al., 2019
whole organism dead, abnormal gper1uab102/uab102 (AB) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 7 from Souder et al., 2019
heart contraction decreased rate, abnormal gper1uab102/+ standard conditions Fig. S7 from Romano et al., 2017
heart contraction rate, ameliorated gper1uab102/+ chemical treatment by environment: 17beta-estradiol Fig. 5 from Romano et al., 2017
Citations